Katrine Mitchell
Foot & Ankle Surgery · Albuquerque, NMNPI 1396857355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Stryker at 59.9% of the total. Reporting peaked in 2019 at $313 and has fallen 62.8% since, to $116 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NM, where the typical reported total is $2,589.
Across 21 payments — averaging $29.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$371
- Treace Medical Concepts, Inc.$61
- Vertex$58
- DJO, LLC$43
- Orthofix Medical, Inc.$18
- Flower Orthopedics Coporation$18
- plus $51 from 3 others
What the payments were for
- Food & beverage$619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $371 |
| Treace Medical Concepts, Inc. | 2 | $61 |
| Vertex | 2 | $58 |
| DJO, LLC | 3 | $43 |
| Orthofix Medical, Inc. | 1 | $18 |
| Flower Orthopedics Coporation | 1 | $18 |
| Davol Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANCHORAGE$126
How this compares
$619 in reported general payments places this provider in the 25th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $1,564 |
| Ciclopirox | 30 | $881 |
| Mupirocin | 17 | $151 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $107 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $98 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Albuquerque
- Mark MargiottaAlbuquerque$12K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
- Marshall MonsonAlbuquerque$9K
- Chad SmithAlbuquerque$9K
- Mark TennyAlbuquerque$8K
- Eve HuiAlbuquerque$6K
- Haywan ChiuAlbuquerque$5K
- Steven WregeAlbuquerque$4K
- Shama PervaizAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.